末梢神経障害治療の世界市場（～2026年）

• 英文タイトル：Global Peripheral Neuropathy Treatment Market Size, Status and Forecast 2020-2026

• レポートコード：MRC2-11QY04222
• 出版社/出版日：QYResearch / 2020年11月20日
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、94ページ
• 納品方法：Eメール（納期：2~3日）
• 産業分類：ヘルスケア

• 販売価格（消費税別）

Single User	￥577,200 (USD3,900)	▷ お問い合わせ
Multi User	￥865,800 (USD5,850)	▷ お問い合わせ
Enterprise License	￥1,154,400 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

当調査資料は末梢神経障害治療のグローバル市場について調査・分析したレポートです。種類別（カルシウムチャネルα2-デルタリガンド、抗うつ薬、オピオイド、その他）市場規模、用途別（プラチナ剤、タキサン、ビンカアルカロイド、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。
・調査範囲
・エグゼクティブサマリー
・企業別末梢神経障害治療の競争状況、市場シェア
・世界の末梢神経障害治療市場：種類別市場規模 2015年-2020年（カルシウムチャネルα2-デルタリガンド、抗うつ薬、オピオイド、その他）
・世界の末梢神経障害治療市場：種類別市場規模予測 2021年-2026年（カルシウムチャネルα2-デルタリガンド、抗うつ薬、オピオイド、その他）
・世界の末梢神経障害治療市場：用途別市場規模 2015年-2020年（プラチナ剤、タキサン、ビンカアルカロイド、その他）
・世界の末梢神経障害治療市場：用途別市場規模予測 2021年-2026年（プラチナ剤、タキサン、ビンカアルカロイド、その他）
・北米の末梢神経障害治療市場分析：米国、カナダ
・ヨーロッパの末梢神経障害治療市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等
・アジアの末梢神経障害治療市場分析：日本、中国、韓国、インド、オーストラリア、台湾等
・中南米の末梢神経障害治療市場分析：メキシコ、ブラジル、アルゼンチン等
・中東・アフリカの末梢神経障害治療市場分析：トルコ、サウジアラビア、UAE等
・企業情報（企業概要、製品概要、販売量、企業動向）
- 掲載企業（変更可能性あり）：Eli Lilly、Johnson & Johnson、Novartis、Pfizer、Aptinyx、Regenacy Pharmaceuticals、TEVA Pharmaceutical Industries、Immune Pharmaceuticals
・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場
・市場機会、課題、リスク、環境分析
・バリューチェーン、販売チャネル分析
・調査の結論

Peripheral neuropathy is a set of symptoms caused by any damage to the nerves that are away from the brain and spinal cord. Peripheral neuropathy is not a single, homogenous disease, but it is a mix of different clinical presentations, natural histories, and pathology.

Market Analysis and Insights: Global Peripheral Neuropathy Treatment Market
The global Peripheral Neuropathy Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.

Global Peripheral Neuropathy Treatment Scope and Market Size
Peripheral Neuropathy Treatment market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Peripheral Neuropathy Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

The key players covered in this study
Eli Lilly
Johnson & Johnson
Novartis
Pfizer
Aptinyx
Regenacy Pharmaceuticals
TEVA Pharmaceutical Industries
Immune Pharmaceuticals

Market segment by Type, the product can be split into
Calcium Channel α2-delta Ligands
Antidepressants
Opioids
Others
Market segment by Application, split into
Platinum Agents
Taxanes
Vinca Alkaloids
Others

Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Peripheral Neuropathy Treatment Revenue
1.4 Market by Type
1.4.1 Global Peripheral Neuropathy Treatment Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Calcium Channel α2-delta Ligands
1.4.3 Antidepressants
1.4.4 Opioids
1.4.5 Others
1.5 Market by Application
1.5.1 Global Peripheral Neuropathy Treatment Market Share by Application: 2020 VS 2026
1.5.2 Platinum Agents
1.5.3 Taxanes
1.5.4 Vinca Alkaloids
1.5.5 Others
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Global Peripheral Neuropathy Treatment Market Perspective (2015-2026)
2.2 Global Peripheral Neuropathy Treatment Growth Trends by Regions
2.2.1 Peripheral Neuropathy Treatment Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Peripheral Neuropathy Treatment Historic Market Share by Regions (2015-2020)
2.2.3 Peripheral Neuropathy Treatment Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Peripheral Neuropathy Treatment Market Growth Strategy
2.3.6 Primary Interviews with Key Peripheral Neuropathy Treatment Players (Opinion Leaders)

3 Competition Landscape by Key Players
3.1 Global Top Peripheral Neuropathy Treatment Players by Market Size
3.1.1 Global Top Peripheral Neuropathy Treatment Players by Revenue (2015-2020)
3.1.2 Global Peripheral Neuropathy Treatment Revenue Market Share by Players (2015-2020)
3.1.3 Global Peripheral Neuropathy Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Peripheral Neuropathy Treatment Market Concentration Ratio
3.2.1 Global Peripheral Neuropathy Treatment Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Peripheral Neuropathy Treatment Revenue in 2019
3.3 Peripheral Neuropathy Treatment Key Players Head office and Area Served
3.4 Key Players Peripheral Neuropathy Treatment Product Solution and Service
3.5 Date of Enter into Peripheral Neuropathy Treatment Market
3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)
4.1 Global Peripheral Neuropathy Treatment Historic Market Size by Type (2015-2020)
4.2 Global Peripheral Neuropathy Treatment Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)
5.1 Global Peripheral Neuropathy Treatment Market Size by Application (2015-2020)
5.2 Global Peripheral Neuropathy Treatment Forecasted Market Size by Application (2021-2026)

6 North America
6.1 North America Peripheral Neuropathy Treatment Market Size (2015-2020)
6.2 Peripheral Neuropathy Treatment Key Players in North America (2019-2020)
6.3 North America Peripheral Neuropathy Treatment Market Size by Type (2015-2020)
6.4 North America Peripheral Neuropathy Treatment Market Size by Application (2015-2020)

7 Europe
7.1 Europe Peripheral Neuropathy Treatment Market Size (2015-2020)
7.2 Peripheral Neuropathy Treatment Key Players in Europe (2019-2020)
7.3 Europe Peripheral Neuropathy Treatment Market Size by Type (2015-2020)
7.4 Europe Peripheral Neuropathy Treatment Market Size by Application (2015-2020)

8 China
8.1 China Peripheral Neuropathy Treatment Market Size (2015-2020)
8.2 Peripheral Neuropathy Treatment Key Players in China (2019-2020)
8.3 China Peripheral Neuropathy Treatment Market Size by Type (2015-2020)
8.4 China Peripheral Neuropathy Treatment Market Size by Application (2015-2020)

9 Japan
9.1 Japan Peripheral Neuropathy Treatment Market Size (2015-2020)
9.2 Peripheral Neuropathy Treatment Key Players in Japan (2019-2020)
9.3 Japan Peripheral Neuropathy Treatment Market Size by Type (2015-2020)
9.4 Japan Peripheral Neuropathy Treatment Market Size by Application (2015-2020)

10 Southeast Asia
10.1 Southeast Asia Peripheral Neuropathy Treatment Market Size (2015-2020)
10.2 Peripheral Neuropathy Treatment Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Peripheral Neuropathy Treatment Market Size by Type (2015-2020)
10.4 Southeast Asia Peripheral Neuropathy Treatment Market Size by Application (2015-2020)

11 India
11.1 India Peripheral Neuropathy Treatment Market Size (2015-2020)
11.2 Peripheral Neuropathy Treatment Key Players in India (2019-2020)
11.3 India Peripheral Neuropathy Treatment Market Size by Type (2015-2020)
11.4 India Peripheral Neuropathy Treatment Market Size by Application (2015-2020)

12 Central & South America
12.1 Central & South America Peripheral Neuropathy Treatment Market Size (2015-2020)
12.2 Peripheral Neuropathy Treatment Key Players in Central & South America (2019-2020)
12.3 Central & South America Peripheral Neuropathy Treatment Market Size by Type (2015-2020)
12.4 Central & South America Peripheral Neuropathy Treatment Market Size by Application (2015-2020)

13 Key Players Profiles
13.1 Eli Lilly
13.1.1 Eli Lilly Company Details
13.1.2 Eli Lilly Business Overview
13.1.3 Eli Lilly Peripheral Neuropathy Treatment Introduction
13.1.4 Eli Lilly Revenue in Peripheral Neuropathy Treatment Business (2015-2020))
13.1.5 Eli Lilly Recent Development
13.2 Johnson & Johnson
13.2.1 Johnson & Johnson Company Details
13.2.2 Johnson & Johnson Business Overview
13.2.3 Johnson & Johnson Peripheral Neuropathy Treatment Introduction
13.2.4 Johnson & Johnson Revenue in Peripheral Neuropathy Treatment Business (2015-2020)
13.2.5 Johnson & Johnson Recent Development
13.3 Novartis
13.3.1 Novartis Company Details
13.3.2 Novartis Business Overview
13.3.3 Novartis Peripheral Neuropathy Treatment Introduction
13.3.4 Novartis Revenue in Peripheral Neuropathy Treatment Business (2015-2020)
13.3.5 Novartis Recent Development
13.4 Pfizer
13.4.1 Pfizer Company Details
13.4.2 Pfizer Business Overview
13.4.3 Pfizer Peripheral Neuropathy Treatment Introduction
13.4.4 Pfizer Revenue in Peripheral Neuropathy Treatment Business (2015-2020)
13.4.5 Pfizer Recent Development
13.5 Aptinyx
13.5.1 Aptinyx Company Details
13.5.2 Aptinyx Business Overview
13.5.3 Aptinyx Peripheral Neuropathy Treatment Introduction
13.5.4 Aptinyx Revenue in Peripheral Neuropathy Treatment Business (2015-2020)
13.5.5 Aptinyx Recent Development
13.6 Regenacy Pharmaceuticals
13.6.1 Regenacy Pharmaceuticals Company Details
13.6.2 Regenacy Pharmaceuticals Business Overview
13.6.3 Regenacy Pharmaceuticals Peripheral Neuropathy Treatment Introduction
13.6.4 Regenacy Pharmaceuticals Revenue in Peripheral Neuropathy Treatment Business (2015-2020)
13.6.5 Regenacy Pharmaceuticals Recent Development
13.7 TEVA Pharmaceutical Industries
13.7.1 TEVA Pharmaceutical Industries Company Details
13.7.2 TEVA Pharmaceutical Industries Business Overview
13.7.3 TEVA Pharmaceutical Industries Peripheral Neuropathy Treatment Introduction
13.7.4 TEVA Pharmaceutical Industries Revenue in Peripheral Neuropathy Treatment Business (2015-2020)
13.7.5 TEVA Pharmaceutical Industries Recent Development
13.8 Immune Pharmaceuticals
13.8.1 Immune Pharmaceuticals Company Details
13.8.2 Immune Pharmaceuticals Business Overview
13.8.3 Immune Pharmaceuticals Peripheral Neuropathy Treatment Introduction
13.8.4 Immune Pharmaceuticals Revenue in Peripheral Neuropathy Treatment Business (2015-2020)
13.8.5 Immune Pharmaceuticals Recent Development

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List of Tables
Table 1. Peripheral Neuropathy Treatment Key Market Segments
Table 2. Key Players Covered: Ranking by Peripheral Neuropathy Treatment Revenue
Table 3. Ranking of Global Top Peripheral Neuropathy Treatment Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Peripheral Neuropathy Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Calcium Channel α2-delta Ligands
Table 6. Key Players of Antidepressants
Table 7. Key Players of Opioids
Table 8. Key Players of Others
Table 9. Global Peripheral Neuropathy Treatment Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 10. Global Peripheral Neuropathy Treatment Market Size by Regions (US$ Million): 2020 VS 2026
Table 11. Global Peripheral Neuropathy Treatment Market Size by Regions (2015-2020) (US$ Million)
Table 12. Global Peripheral Neuropathy Treatment Market Share by Regions (2015-2020)
Table 13. Global Peripheral Neuropathy Treatment Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 14. Global Peripheral Neuropathy Treatment Market Share by Regions (2021-2026)
Table 15. Market Top Trends
Table 16. Key Drivers: Impact Analysis
Table 17. Key Challenges
Table 18. Peripheral Neuropathy Treatment Market Growth Strategy
Table 19. Main Points Interviewed from Key Peripheral Neuropathy Treatment Players
Table 20. Global Peripheral Neuropathy Treatment Revenue by Players (2015-2020) (Million US$)
Table 21. Global Peripheral Neuropathy Treatment Market Share by Players (2015-2020)
Table 22. Global Top Peripheral Neuropathy Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Peripheral Neuropathy Treatment as of 2019)
Table 23. Global Peripheral Neuropathy Treatment by Players Market Concentration Ratio (CR5 and HHI)
Table 24. Key Players Headquarters and Area Served
Table 25. Key Players Peripheral Neuropathy Treatment Product Solution and Service
Table 26. Date of Enter into Peripheral Neuropathy Treatment Market
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Peripheral Neuropathy Treatment Market Size by Type (2015-2020) (Million US$)
Table 29. Global Peripheral Neuropathy Treatment Market Size Share by Type (2015-2020)
Table 30. Global Peripheral Neuropathy Treatment Revenue Market Share by Type (2021-2026)
Table 31. Global Peripheral Neuropathy Treatment Market Size Share by Application (2015-2020)
Table 32. Global Peripheral Neuropathy Treatment Market Size by Application (2015-2020) (Million US$)
Table 33. Global Peripheral Neuropathy Treatment Market Size Share by Application (2021-2026)
Table 34. North America Key Players Peripheral Neuropathy Treatment Revenue (2019-2020) (Million US$)
Table 35. North America Key Players Peripheral Neuropathy Treatment Market Share (2019-2020)
Table 36. North America Peripheral Neuropathy Treatment Market Size by Type (2015-2020) (Million US$)
Table 37. North America Peripheral Neuropathy Treatment Market Share by Type (2015-2020)
Table 38. North America Peripheral Neuropathy Treatment Market Size by Application (2015-2020) (Million US$)
Table 39. North America Peripheral Neuropathy Treatment Market Share by Application (2015-2020)
Table 40. Europe Key Players Peripheral Neuropathy Treatment Revenue (2019-2020) (Million US$)
Table 41. Europe Key Players Peripheral Neuropathy Treatment Market Share (2019-2020)
Table 42. Europe Peripheral Neuropathy Treatment Market Size by Type (2015-2020) (Million US$)
Table 43. Europe Peripheral Neuropathy Treatment Market Share by Type (2015-2020)
Table 44. Europe Peripheral Neuropathy Treatment Market Size by Application (2015-2020) (Million US$)
Table 45. Europe Peripheral Neuropathy Treatment Market Share by Application (2015-2020)
Table 46. China Key Players Peripheral Neuropathy Treatment Revenue (2019-2020) (Million US$)
Table 47. China Key Players Peripheral Neuropathy Treatment Market Share (2019-2020)
Table 48. China Peripheral Neuropathy Treatment Market Size by Type (2015-2020) (Million US$)
Table 49. China Peripheral Neuropathy Treatment Market Share by Type (2015-2020)
Table 50. China Peripheral Neuropathy Treatment Market Size by Application (2015-2020) (Million US$)
Table 51. China Peripheral Neuropathy Treatment Market Share by Application (2015-2020)
Table 52. Japan Key Players Peripheral Neuropathy Treatment Revenue (2019-2020) (Million US$)
Table 53. Japan Key Players Peripheral Neuropathy Treatment Market Share (2019-2020)
Table 54. Japan Peripheral Neuropathy Treatment Market Size by Type (2015-2020) (Million US$)
Table 55. Japan Peripheral Neuropathy Treatment Market Share by Type (2015-2020)
Table 56. Japan Peripheral Neuropathy Treatment Market Size by Application (2015-2020) (Million US$)
Table 57. Japan Peripheral Neuropathy Treatment Market Share by Application (2015-2020)
Table 58. Southeast Asia Key Players Peripheral Neuropathy Treatment Revenue (2019-2020) (Million US$)
Table 59. Southeast Asia Key Players Peripheral Neuropathy Treatment Market Share (2019-2020)
Table 60. Southeast Asia Peripheral Neuropathy Treatment Market Size by Type (2015-2020) (Million US$)
Table 61. Southeast Asia Peripheral Neuropathy Treatment Market Share by Type (2015-2020)
Table 62. Southeast Asia Peripheral Neuropathy Treatment Market Size by Application (2015-2020) (Million US$)
Table 63. Southeast Asia Peripheral Neuropathy Treatment Market Share by Application (2015-2020)
Table 64. India Key Players Peripheral Neuropathy Treatment Revenue (2019-2020) (Million US$)
Table 65. India Key Players Peripheral Neuropathy Treatment Market Share (2019-2020)
Table 66. India Peripheral Neuropathy Treatment Market Size by Type (2015-2020) (Million US$)
Table 67. India Peripheral Neuropathy Treatment Market Share by Type (2015-2020)
Table 68. India Peripheral Neuropathy Treatment Market Size by Application (2015-2020) (Million US$)
Table 69. India Peripheral Neuropathy Treatment Market Share by Application (2015-2020)
Table 70. Central & South America Key Players Peripheral Neuropathy Treatment Revenue (2019-2020) (Million US$)
Table 71. Central & South America Key Players Peripheral Neuropathy Treatment Market Share (2019-2020)
Table 72. Central & South America Peripheral Neuropathy Treatment Market Size by Type (2015-2020) (Million US$)
Table 73. Central & South America Peripheral Neuropathy Treatment Market Share by Type (2015-2020)
Table 74. Central & South America Peripheral Neuropathy Treatment Market Size by Application (2015-2020) (Million US$)
Table 75. Central & South America Peripheral Neuropathy Treatment Market Share by Application (2015-2020)
Table 76. Eli Lilly Company Details
Table 77. Eli Lilly Business Overview
Table 78. Eli Lilly Product
Table 79. Eli Lilly Revenue in Peripheral Neuropathy Treatment Business (2015-2020) (Million US$)
Table 80. Eli Lilly Recent Development
Table 81. Johnson & Johnson Company Details
Table 82. Johnson & Johnson Business Overview
Table 83. Johnson & Johnson Product
Table 84. Johnson & Johnson Revenue in Peripheral Neuropathy Treatment Business (2015-2020) (Million US$)
Table 85. Johnson & Johnson Recent Development
Table 86. Novartis Company Details
Table 87. Novartis Business Overview
Table 88. Novartis Product
Table 89. Novartis Revenue in Peripheral Neuropathy Treatment Business (2015-2020) (Million US$)
Table 90. Novartis Recent Development
Table 91. Pfizer Company Details
Table 92. Pfizer Business Overview
Table 93. Pfizer Product
Table 94. Pfizer Revenue in Peripheral Neuropathy Treatment Business (2015-2020) (Million US$)
Table 95. Pfizer Recent Development
Table 96. Aptinyx Company Details
Table 97. Aptinyx Business Overview
Table 98. Aptinyx Product
Table 99. Aptinyx Revenue in Peripheral Neuropathy Treatment Business (2015-2020) (Million US$)
Table 100. Aptinyx Recent Development
Table 101. Regenacy Pharmaceuticals Company Details
Table 102. Regenacy Pharmaceuticals Business Overview
Table 103. Regenacy Pharmaceuticals Product
Table 104. Regenacy Pharmaceuticals Revenue in Peripheral Neuropathy Treatment Business (2015-2020) (Million US$)
Table 105. Regenacy Pharmaceuticals Recent Development
Table 106. TEVA Pharmaceutical Industries Company Details
Table 107. TEVA Pharmaceutical Industries Business Overview
Table 108. TEVA Pharmaceutical Industries Product
Table 109. TEVA Pharmaceutical Industries Revenue in Peripheral Neuropathy Treatment Business (2015-2020) (Million US$)
Table 110. TEVA Pharmaceutical Industries Recent Development
Table 111. Immune Pharmaceuticals Business Overview
Table 112. Immune Pharmaceuticals Product
Table 113. Immune Pharmaceuticals Company Details
Table 114. Immune Pharmaceuticals Revenue in Peripheral Neuropathy Treatment Business (2015-2020) (Million US$)
Table 115. Immune Pharmaceuticals Recent Development
Table 116. Research Programs/Design for This Report
Table 117. Key Data Information from Secondary Sources
Table 118. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Peripheral Neuropathy Treatment Market Share by Type: 2020 VS 2026
Figure 2. Calcium Channel α2-delta Ligands Features
Figure 3. Antidepressants Features
Figure 4. Opioids Features
Figure 5. Others Features
Figure 6. Global Peripheral Neuropathy Treatment Market Share by Application: 2020 VS 2026
Figure 7. Platinum Agents Case Studies
Figure 8. Taxanes Case Studies
Figure 9. Vinca Alkaloids Case Studies
Figure 10. Others Case Studies
Figure 11. Peripheral Neuropathy Treatment Report Years Considered
Figure 12. Global Peripheral Neuropathy Treatment Market Size YoY Growth 2015-2026 (US$ Million)
Figure 13. Global Peripheral Neuropathy Treatment Market Share by Regions: 2020 VS 2026
Figure 14. Global Peripheral Neuropathy Treatment Market Share by Regions (2021-2026)
Figure 15. Porter's Five Forces Analysis
Figure 16. Global Peripheral Neuropathy Treatment Market Share by Players in 2019
Figure 17. Global Top Peripheral Neuropathy Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Peripheral Neuropathy Treatment as of 2019
Figure 18. The Top 10 and 5 Players Market Share by Peripheral Neuropathy Treatment Revenue in 2019
Figure 19. North America Peripheral Neuropathy Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Europe Peripheral Neuropathy Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. China Peripheral Neuropathy Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Japan Peripheral Neuropathy Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Southeast Asia Peripheral Neuropathy Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. India Peripheral Neuropathy Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Central & South America Peripheral Neuropathy Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. Bottom-up and Top-down Approaches for This Report
Figure 27. Data Triangulation
Figure 28. Key Executives Interviewed

以下、関連資料のご紹介

糖尿病性末梢神経障害治療の世界市場（～2026年）

Global Diabetic Peripheral Neuropathy Treatment Market Size, Status and Forecast 2020-2026
MRC2-11QY11635 2020年11月25日 96Pages
当調査資料は糖尿病性末梢神経障害治療のグローバル市場について調査・分析したレポートです。種類別（アンチムノセル、ASP-8477、BNV-222、カプサイシン、CBX-129801、その他）市場規模、用途別（病院、クリニック、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス...

心臓自律神経障害治療の世界市場（～2026年）

Global Cardiac Autonomic Neuropathy Treatment Market Size, Status and Forecast 2020-2026
MRC2-11QY11257 2020年11月25日 99Pages
当調査資料は心臓自律神経障害治療のグローバル市場について調査・分析したレポートです。種類別（固形経口、注射剤）市場規模、用途別（病院、心臓センター、外来手術センター）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オー...

視神経症薬の世界市場（～2026年）

Global Optic Neuropathy Drug Market Insights and Forecast to 2026
MRC2-11QY08387 2020年11月20日 115Pages
当調査資料は視神経症薬のグローバル市場について調査・分析したレポートです。種類別（BA-240、IWP-953、LM-22A4、その他）市場規模、用途別（クリニック、病院、在宅医療）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓...

レーバー遺伝性視神経症治療薬の世界市場（～2026年）

Global Leber's Hereditary Optic Neuropathy Drug Market Insights and Forecast to 2026
MRC2-11QY07145 2020年11月20日 115Pages
当調査資料はレーバー遺伝性視神経症治療薬のグローバル市場について調査・分析したレポートです。種類別（エラミプレチド、GS-011、IXC-201、KH-176、その他）市場規模、用途別（病院、診療所、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシ...

末梢動脈疾患（PAD）薬の世界市場（～2026年）

Global Peripheral Arterial Disease (PAD) Drugs Market Size, Status and Forecast 2020-2026
MRC2-11QY04220 2020年11月20日 90Pages
当調査資料は末梢動脈疾患（PAD）薬のグローバル市場について調査・分析したレポートです。種類別（クロピドグレル（プラビックス）、プラスグレル（効率的）、チカグレロル（ブリリンタ）、ボラパクサー（帯状）、その他）市場規模、用途別（病院、診療所、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、...

糖尿病治療の世界市場（～2026年）

Global Diabetes Treatment Market Size, Status and Forecast 2020-2026
MRC2-11QY11629 2020年11月25日 96Pages
当調査資料は糖尿病治療のグローバル市場について調査・分析したレポートです。種類別（インスリン、経口血糖降下薬、非インスリン注射薬、その他）市場規模、用途別（病院、個人、クリニック）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国...

末梢動脈疾患（PAD）治療薬の世界市場（～2026年）

Global Peripheral Arterial Disease (PAD) Therapeutics Market Size, Status and Forecast 2020-2026
MRC2-11QY04221 2020年11月20日 94Pages
当調査資料は末梢動脈疾患（PAD）治療薬のグローバル市場について調査・分析したレポートです。種類別（抗血小板薬、二重抗血小板療法薬、その他）市場規模、用途別（病院、診療所、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国...

皮膚糸状菌性爪真菌症治療（DOT）の世界市場（～2026年）

Global Dermatophytic Onychomycosis Treatment Market Size, Status and Forecast 2020-2026
MRC2-11QY11622 2020年11月25日 98Pages
当調査資料は皮膚糸状菌性爪真菌症治療（DOT）のグローバル市場について調査・分析したレポートです。種類別（全身療法、局所療法、その他）市場規模、用途別（病院、皮膚科クリニック、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、...

目アレルギー治療の世界市場（～2026年）

Global Eye Allergy Treatment Market Size, Status and Forecast 2020-2026
MRC2-11QY11906 2020年11月25日 98Pages
当調査資料は目アレルギー治療のグローバル市場について調査・分析したレポートです。種類別（薬、アレルギーショット、その他）市場規模、用途別（病院、眼科クリニック）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラ...

線維肉腫治療の世界市場（～2026年）

Global Fibrosarcoma Treatment Market Size, Status and Forecast 2020-2026
MRC2-11QY11943 2020年11月25日 95Pages
当調査資料は線維肉腫治療のグローバル市場について調査・分析したレポートです。種類別（化学療法、放射線療法、手術、その他）市場規模、用途別（病院、クリニック、専門がん治療センター、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国...

糖尿病性末梢神経障害治療の世界市場（～2026年） Market Analysis and Insights: Global Diabetic Peripheral Neuropathy Treatment Market The global Diabetic Peripheral Neuropathy Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Diabetic Peripheral Neuropathy Tr…
心臓自律神経障害治療の世界市場（～2026年） Cardiac Autonomic Neuropathy treatment market involves aggressively treating cardiovascular risk factors like hypertension. Cardiac autonomicdeficiency of essential fatty acids, increased oxidative stress, autoimmune damage, and formation of advanced glycosylation end products. Other therapies inclu…
PC/Macゲーマー・PC/Macゲーミング周辺機器の世界市場（～2026年） Mac gaming refers to use of video games on Macintosh personal computers. The key factor contributing to the PC/Mac gamer and PC/Mac gaming peripheral market is the rising disposable income in inviduals. Market Analysis and Insights: Global PC/Mac Gamer and PC/Mac Gaming Peripheral Market The global …
視神経症薬の世界市場（～2026年） Market Analysis and Insights: Global Optic Neuropathy Drug Market The global Optic Neuropathy Drug market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Optic Neuropathy Drug Scope and Market Size Optic Neuropathy Drug marke…
レーバー遺伝性視神経症治療薬の世界市場（～2026年） Market Analysis and Insights: Global Leber's Hereditary Optic Neuropathy Drug Market The global Leber's Hereditary Optic Neuropathy Drug market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Leber's Hereditary Optic Neuropat…